Elmsford, NY, United States of America

Harry R Leipold

This inventor holds 19 USPTO granted patents and 1 EPO patent, primarily in Active Agent Delivery. Top assignees: Emisphere Technologies, Inc., Mhr Institutional Partners Iia LP. Active years: 1998-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry R Leipold. Retrieved from https://idiyas.com/inventor/harry-r-leipold

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 84.2


Average Co-Inventor Count = 4.3

ph-index = 16

Forward Citations = 733(Granted Patents)


Company Filing History:


Years Active: 1998-2008

Loading Chart...
Loading Chart...
Areas of Expertise:
Active Agents
Transport Systems
Compositions
Delivery Systems
Pharmaceuticals
Formulations
Bioavailability
Chemical Compounds
Drug Delivery
Encapsulation
19 patents (USPTO):Explore Patents

Title: Spotlight on Inventor Harry R Leipold

Introduction:

Harry R Leipold, a prolific inventor based in Elmsford, NY, has left a lasting impact on the field of active agent delivery. With an impressive portfolio of 19 patents, Leipold's innovative contributions have significantly advanced the realms of pharmaceuticals and drug delivery systems.

Latest Patents:

Leipold's latest patents showcase his expertise in developing compounds and compositions for delivering active agents. These inventions include modified amino acid compounds and carrier compounds that are instrumental in enhancing the efficacy of active agents. The methods of administration and preparation provided in these patents underscore Leipold's commitment to improving therapeutic outcomes for patients.

Career Highlights:

Throughout his career, Leipold has worked with esteemed companies such as Emisphere Technologies, Inc. and Mhr Institutional Partners Iia LP. His professional journey has been marked by a relentless pursuit of innovation and a dedication to pushing the boundaries of what is possible in the realm of active agent delivery.

Collaborations:

In his collaborative efforts, Leipold has had the privilege of working alongside accomplished individuals in the industry. Notable coworkers such as Andrea Leone-Bay and Donald J Sarubbi have contributed to Leipold's success, creating a synergy that has resulted in groundbreaking advancements in drug delivery technologies.

Conclusion:

Inventor Harry R Leipold's remarkable body of work stands as a testament to his ingenuity and vision in the field of active agent delivery. His patents and collaborations have not only enriched the scientific community but have also paved the way for transformative developments in pharmaceuticals. Leipold's contributions serve as inspiration for future innovators seeking to make a profound impact on the world of healthcare and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…